
Denmark · Biotechnology startup
Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution.
Funding reportedLast round: Undisclosed round
Follow Visiopharm and see its new rounds in your feed.Start following
Funding, as reported
From Visiopharm's own website: 7 on the team.
Add your raise, your deck and your story, and put Visiopharm in front of investors. Or tell us what we have wrong.